Citation: T. Hovi et al., Poliovirus surveillance by examining sewage specimens. Quantitative recovery of virus after introduction into sewerage at remote upstream location, EPIDEM INFE, 127(1), 2001, pp. 101-106
Citation: H. Sormunen et al., Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine, J MED VIROL, 63(4), 2001, pp. 305-310
Citation: T. Hovi et M. Stenvik, Surveillance of patients with acute flaccid paralysis in Finland: report of a pilot study, B WHO, 78(3), 2000, pp. 298-304
Authors:
Rosenlew, M
Stenvik, M
Roivainen, M
Jarvenpaa, AL
Hovi, T
Citation: M. Rosenlew et al., A population-based prospective survey of newborn infants with suspected systemic infection: occurrence of sporadic enterovirus and adenovirus infections, J CLIN VIRO, 12(3), 1999, pp. 211-219
Authors:
Piirainen, L
Stenvik, M
Roivainen, M
Eskola, J
Beuvery, EC
Hovi, T
Citation: L. Piirainen et al., Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus, VACCINE, 17(9-10), 1999, pp. 1084-1090
Authors:
Raty, R
Kleemola, M
Melen, K
Stenvik, M
Julkunen, I
Citation: R. Raty et al., Efficacy of PCR and other diagnostic methods for the detection of respiratory adenoviral infections, J MED VIROL, 59(1), 1999, pp. 66-72
Authors:
Mulders, MN
Reimerink, JHJ
Stenvik, M
Alaeddinoglu, I
van der Avoort, HGAM
Hovi, T
Koopmans, MPG
Citation: Mn. Mulders et al., A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1, J GEN VIROL, 80, 1999, pp. 907-916